share_log

Chardan Capital Reiterates Buy on Senti Biosciences, Maintains $6 Price Target

Benzinga ·  Aug 15, 2023 04:25

Chardan Capital analyst Geulah Livshits reiterates Senti Biosciences (NASDAQ:SNTI) with a Buy and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment